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a b s t r a c t
Neural crest development is orchestrated by a complex and still poorly understood gene regulatory
network. Premigratory neural crest is induced at the lateral border of the neural plate by the combined
action of signaling molecules and transcription factors such as AP2, Gbx2, Pax3 and Zic1. Among them,
Pax3 and Zic1 are both necessary and sufﬁcient to trigger a complete neural crest developmental
program. However, their gene targets in the neural crest regulatory network remain unknown. Here,
through a transcriptome analysis of frog microdissected neural border, we identiﬁed an extended gene
signature for the premigratory neural crest, and we deﬁned novel potential members of the regulatory
network. This signature includes 34 novel genes, as well as 44 known genes expressed at the neural
border. Using another microarray analysis which combined Pax3 and Zic1 gain-of-function and protein
translation blockade, we uncovered 25 Pax3 and Zic1 direct targets within this signature. We
demonstrated that the neural border speciﬁers Pax3 and Zic1 are direct upstream regulators of neural
crest speciﬁers Snail1/2, Foxd3, Twist1, and Tfap2b. In addition, they may modulate the transcriptional
output of multiple signaling pathways involved in neural crest development (Wnt, Retinoic Acid)
through the induction of key pathway regulators (Axin2 and Cyp26c1). We also found that Pax3 could
maintain its own expression through a positive autoregulatory feedback loop. These hierarchical
inductions, feedback loops, and pathway modulations provide novel tools to understand the neural
crest induction network.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Patterning the embryo implies the precise orchestration of
gene activities in time and space. This involves coordinated trans-
criptional and posttranscriptional regulations. Despite advances in
the inference of complex transcriptional gene regulatory networks
in invertebrate embryos (Busser et al., 2012; Gohlke et al., 2008;
Hertzano et al., 2011; Isern et al., 2011; Lagha et al., 2010; Taher
et al., 2011), this task remains challenging for early vertebrate
embryogenesis. We focus on vertebrate neural crest induction, in
which early transcriptional regulators activate a complex devel-
opmental network, and in which transcriptome analysis can be
combined with in vivo experimental validation.
The neural crest arises between neural plate and epidermis
at the “neural border”. Neural crest progenitors undergo an
epithelial-to-mesenchymal transition (EMT) and generate migra-
tory cells that populate many tissues and organs in the embryo.
The neural crest cells form the peripheral nervous system, pig-
ment cells, craniofacial cartilage and mesenchyme, endocrine cells
and other derivatives (Le Douarin and Kalcheim, 1999). While
neural crest migration and differentiation have been studied
extensively, the molecular mechanisms that initiate neural crest
development within the dorsal neural tube have remained elusive
until recently. The neural border, which contains both neural crest
and dorsal neural tube progenitors, is ﬁrst patterned under the
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activity of secreted signals coming from the surrounding tissues:
ectoderm, mesoderm, neural plate and notochord. FGF, Wnt and
BMP signaling activate or enhance the expression of a ﬁrst set of
essential genes named the neural border speciﬁers (Chang and
Hemmati-Brivanlou, 1998; LaBonne and Bronner-Fraser, 1998;
Monsoro-Burq et al., 2003; Saint-Jeannet et al., 1997; Villanueva
et al., 2002, reviewed in Milet and Monsoro-Burq, 2012). These
neural border speciﬁers include the transcription factors Pax3,
Pax7, Gbx2, Msx1, Zic1, AP2, and Hairy2, which are essential for
further neural crest development but not always maintained in the
neural crest progenitors themselves (Basch et al., 2006; Li et al.,
2009; Luo et al., 2003; Maczkowiak et al., 2010; Monsoro-Burq
et al., 2005; Nichane et al., 2008; Sato et al., 2005). The combined
activity of the neural border speciﬁers establishes a robust neural
border territory during gastrulation (Basch et al., 2006; de Croze
et al., 2011; Li et al., 2009). Some will then speciﬁcally induce the
premigratory neural crest during neurulation (reviewed in
Pegoraro and Monsoro-Burq, 2013). We have shown recently that
Pax3 initiates neural crest development from pluripotent ecto-
derm, most efﬁciently when it is co-expressed with Zic1. Pax3 and
Zic1 expressed together are sufﬁcient to drive premigratory neural
crest induction, EMT, migration and differentiation of multiple
neural crest derivatives while Pax3 expression alone drives a modest
induction, migration and differentiation (Milet et al., 2013).
To decipher the transcriptional responses activated by Pax3 and
Zic1 during neural crest induction, we focused on genes activated
as immediate early targets, i.e. in the absence of protein synthesis
(Sive et al., 1984). Furthermore, since Pax3 and Zic1 also play roles
in the development of other tissues such as muscles and cerebel-
lum respectively (Nagai et al., 1997; Nakata et al., 1997, 1998,
2000; Relaix et al., 2004; Tremblay et al., 1996, 1998; Zhou et al.,
2008), we also deﬁned a large gene signature of the neural border
and of the premigratory neural crest. This molecular signature
provides the Pax3 and Zic1 targets likely to be relevant for neural
crest development. In addition, we assayed Pax3 either alone or
together with Zic1, to determine whether they activate separate
sets of target genes that would then cooperate, or if some novel
targets are activated only when the two factors are combined.
Finally, we asked whether Pax3 and Zic1 induced a subset of
neural crest speciﬁer genes, which would in turn switch on
secondary targets, or if Pax3 and Zic1 simultaneously activate a
large set of neural crest speciﬁers.
Materials and methods
Embryos, explants, in vivo injections and treatments.
Xenopus laevis embryos were obtained using standard proce-
dures (Sive et al., 2000). Neurula stage 12, 14 and 18 control
embryos were used for neural plate, neural border and neural crest
dissection (Fig. 1A). For microinjections, two-cell stage embryos
were injected into both blastomeres, aged until blastula stage
9 when the animal-most third of the animal hemisphere (the
animal cap) was cut. Animal caps were cultured in 3/4 Normal
Amphibian Medium until the desired stage (Sive et al., 2000).
Capped mRNAs for the previously described inducible pax3GR and
zic1GR constructs (Hong and Saint-Jeannet, 2007) were synthe-
sized in vitro using mMessage mMachine kits (Ambion). Pax3 and
Zic1 antisense morpholino oligonucleotides were validated pre-
viously (de Croze et al., 2011; Monsoro-Burq et al., 2005). For
neural crest induction in animal cap pluripotent ectoderm in the
absence of protein synthesis, inducible Pax3 and Zic1 mRNAs were
injected in whole embryos at the 2 cells stage as described
previously (Hong and Saint-Jeannet, 2007; Milet et al., 2013).
Animal caps were cut at stage 9. Cycloheximide (0,1 mg/ml) was
Fig. 1. Identiﬁcation of the premigratory neural crest transcriptome signature during neurulation (A) Several types of early embryo explants were dissected for microarray
analysis: the animal cap ectoderm, cut at blastula stage 9 and allowed to develop until stage 14 in vitro (AC14), the early neural plate at stage 12 (NP12), the lateral neural
border at stage 14 (NB14), the premigratory cranial neural crest and its overlying ectoderm at stage 18 (NB18), and the anterior neural fold at stage 18 (ANF18). Expression
level thresholding, differential analysis, and clustering deﬁned a group of 83 genes enriched in neural border samples. (B) Outline of the experimental strategy used to
identify the neural crest transcriptome signature.
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then applied to the healed animal caps, from stage 10 to 10.5 (i.e.
for 30 min at 23 1C), then dexamethasone (Kolm and Sive, 1995)
was added at stage 10.5 to the cycloheximide-containing medium
(Sive et al., 1984). Explants were rinced and lysed after two
additional hours at 23 1C, i.e. when sibling embryos reached stage
11.5–12.
Microarray data analysis.
For all microarray analysis, biological replicates were obtained
from 80 manually dissected explants from sibling embryos. Total
RNA was extracted with Trizol (Invitrogen) and puriﬁed according
to a standard protocol (Lin et al., 2004), modiﬁed to include a
proteinase K digestion step to remove yolk phospholipoproteins.
The detailed modiﬁed protocol is described in Supplemental
Materials. Ten micrograms of total RNA were used to prepare
cDNAs and labeled RNA probes that were hybridized to X. laevis
Affymetrix GeneChips using the standard Affymetrix protocol (UC
Berkeley Affymetrix facility). X. laevis 1.0 GeneChips were used to
measure the neural border transcriptome and X. laevis 2.0 Gene-
Chips were used for the Pax3/Zic1 targets experiment. Raw
expression level for each probeset was normalized with RMA
(Robust Multi-array Average, Bioconductor Affy package) prior to
analysis. The R programming environment with Bioconductor and
LIMMA packages (Gentleman et al., 2004; Smyth, 2004), was used
for the analysis. Probesets were selected according to the following
criteria: expression threshold 47; signiﬁcant differential expres-
sion between samples (logFold 41 and pvalue o2.5%). For
hierarchical clustering, the data matrix was preprocessed by
averaging gene expression over biological replicates of the same
tissue, then centering and normalizing the expression vector.
Hierarchical clustering was then computed using the centroid
linkage algorithm and correlation distance as implemeted in Gene
Cluster 3.0 (de Hoon et al., 2004). Annotation of the Affymetrix
Genechips was obtained from Xenbase (www.xenbase.org) and
Affymetrix (www.affymetrix.com). Unannotated probesets were
identiﬁed by similarity searches in the X. laevis genome (www.
xenbase.org, version 6). Functional annotation with PIR keywords
was conducted with DAVID (david.abcc.ncifcrf.gov) using the more
thorough human orthologs annotations. The effect of Pax3 and
Zic1 expression on the blastocoel roof ectoderm transcriptome
was modeled using the limma package taking into account
biological replicate effect. Genes signiﬁcantly overexpressed were
identiﬁed using the limma package. Enrichment of neural crest
signature genes in the identiﬁed targets was assessed using a chi-
square test. The data have been submitted to GEO with the
following reference numbers: GSE53677, GSE53678, GSE53679.
In situ hybridization
Embryos were stained by whole mount in situ hybridization
using a procedure optimized for neural and neural crest tissues
(Monsoro-Burq, 2007). They were then bleached, postﬁxed, and
imaged using a MZFLIII stereoscope (Leica), Photoshop CS, and
CombineZP software (hadleyweb.pwp.blueyonder.co.uk). cDNAs
for novel genes were either purchased from Open Biosystems or
cloned by nested PCR and inserted into the pGEM-T Easy vector
(Promega). Primers and clone references are shown in Table S1.
RT-PCR, RT-qPCR, electrophoresis mobility shift assay (EMSA)
Reverse transcription was followed by semi-quantitative radio-
active PCR or quantitative PCR. Odc was used as a reference to
normalize measurements. Primers for axin2, c3, cyp26c1, dusp5,
ets1, pax3, pdgfra, snail1, snail2, and twist1 are described in
Table S1.
X. tropicalis genome browsers, Transfac, Jaspar, rVista and
MacVector analyses (gene-regulation.com; jaspar.genereg.net;
rvista.dcode.org; macvector.com) were used to identify putative
Pax3 or Zic1-binding sites in pax3, snail1 and snail2 genome
sequences upstream their transcription start site (TSS). 50-base
length primers containing the putative binding site as well as their
corresponding mutants (Table S1) were designed and used to
perform EMSA according to standard procedures. Pax3 and Zic1
proteins were produced in HEK-293 cells, and lysates obtained by
cryo-lysis. Controls were GFP-transfected cells. Pax3 monoclonal
antibody (R&D Systems) and a non-speciﬁc control antibody
(Sigma P0498) were used for supershift assays.
Results
Identiﬁcation of a novel gene signature for premigratory cephalic NC.
Five types of tissue samples were collected to identify neural
crest signature transcripts, focusing on premigratory cephalic NC:
the cephalic lateral neural border at stage 14 (3 biological
replicates), the premigratory cranial neural crest at stage 18 with
its overlying ectoderm (2 biological replicates), the anterior neural
border at stage 18 (3 biological replicates), the neural plate
including its lateral neural border at stage 12 (2 biological
replicates), and animal cap explants cut at stage 9 and grown
until stage 14 (1 sample) (Fig. 1A). Transcripts were ﬁrst selected
using two threshold criteria (Fig. 1B). (Criterion 1) Transcripts were
required to exceed a deﬁned expression threshold (7.0) in at least
one neural border/NC sample. This threshold was selected because
it is met by known neural crest regulators (pax3, zic1, msx1, snail2,
foxd3), in order to select only robustly expressed genes. (Criterion
2) Transcripts needed to be signiﬁcantly overexpressed (at least 2-
fold with limma package) in neural border/NC samples (at stage 14
or 18) in comparison with anterior neural fold (stage 18) samples,
which do not form neural crest. 206 genes met these criteria.
Additionally, we grouped genes with similar expression in all
tissues collected using hierarchical clustering. The cluster contain-
ing the known neural crest regulators foxd3, pax3, snail1, snail2,
and zic1 was considered as the putative neural crest signature
cluster.
This cluster contains 83 genes including 44 (53%) genes known
to be expressed at the neural border or in the neural crest (Table
S2). In addition, the cluster contains 34 (41%) novel genes whose
expression during neural crest induction has not been previously
described (Table S2). Finally, ﬁve (6%) genes show no expression
overlap with the neural border and neural crest, three being
expressed in the ectoderm overlying the neural border that was
included in the dissections, and two being actin genes expressed
Table 1
Functional terms enriched in the neural crest transcriptome signature.
PIR keywords Count Adjusted p-value
Developmental protein 19 (27%) 2.7E8
DNA binding 24 (34%) 5.1E6
Homeobox 8 (11%) 1.3E3
Disease mutation 18 (25%) 1.3E3
Waardenburg syndrome 3 (4%) 5.9E3
Wnt signaling pathway 6 (9%) 2.4E3
Signal 23 (32%) 2.5E2
Extracellular matrix 6 (9%) 2.4E2
Functional enrichment was computed using annotations of the frog genes human
orthologs. Out of 83 genes, annotations were available for 71 of them, which
represents the total count. The Signal category corresponds to proteins containing a
signal peptide. Disease mutation corresponds to proteins found mutated in a
genetic disease.
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in the underlying mesoderm. Functional annotation shows that
DNA binding proteins, the Wnt signaling pathway, and proteins
containing extracellular domains are signiﬁcantly enriched in this
cluster (Tables 1 and 2).
We next validated a subset of the predicted early NC signature
genes, by analyzing their expression pattern in vivo. Gastrula,
neurula, and tailbud stage embryos were analyzed and compared
to pax3 and snai2 expression (Fig. 2 and data not shown).
Transcripts for all the predicted genes were found robustly
expressed at the lateral neural border or in the neural crest.
Speciﬁcally, we found a ﬁrst group of genes, including greb1L,
phnd, and tcf7, which are enriched at the neural border in early
neurulae. These transcripts are then either maintained in the
dorsal neural tube and NC (greb1L, tcf7, Fig. 2E-F, I-J) or later
excluded from the NC (phnd, Fig. 2G and H). This dynamic
expression is similar to that of neural border speciﬁers such as
pax3 or msx1 (Fig. 2A and B, Monsoro-Burq et al., 2005). The
second group of genes was expressed at later neurula stage: the
stage 18 premigratory neural crest expressed hapln3, kal1, mfap2,
and odz4 (Fig. 2K and P and S and T). Mmp28 transcripts were
found at the edge of the neural crest domain (Fig. 2Q and R). At
tailbud stage, kal1 and mfap2 were robustly expressed by the
migrating cranial neural crest, while odz4 and mmp28 were found
as discrete lines in the craniofacial structures (Fig. 2N, P, R, and T).
Hapln3 remained expressed in the neural tube and around the
eyes (Fig. 2L). Altogether, these observations validate the accuracy
of the predicted gene signature for neural border and premigra-
tory neural crest. This analysis thus provides 34 novel candidates
for future analyses of NC development. Here, we have used this
gene signature to identify gene targets of the two major neural
crest inducers, Pax3 and Zic1.
Identiﬁcation of putative Pax3 targets within the NC gene signature.
To identify immediate-early targets of Pax3 and Zic1 within the
neural crest signature using a transcriptomic approach, we ana-
lyzed 3 biological replicates for each of the following conditions:
uninjected animal caps, animal caps injected with Pax3GR alone;
or animal caps injected with Pax3GR and Zic1GR. We treated
explants with cycloheximide, a translation inhibitor, to prevent
secondary target induction by Pax3 and Zic1 targets, and with
dexamethasone that induces nuclear translocation of GR fusion
proteins (Fig. 3A). We found 450 transcripts enriched more than
2-fold (but less than 4-folds) and 160 enriched more than 4-folds
when Pax3GR was induced in the presence of cycloheximide,
compared to the uninduced ectoderm (Fig. 3B). Among these 610
transcripts, 21 belonged to the neural crest signature deﬁned
above. This represents a signiﬁcant enrichment (po0.001) of
neural crest signature genes among Pax3 targets. Among these,
we found several known neural border speciﬁers (tfap2b, pax3,
zic1) (reviewed in Pegoraro and Monsoro-Burq, 2013), known
neural crest speciﬁers (snail1, snail2, foxd3, twist1, ets1) (reviewed
in Rogers et al., 2012) and other neural border/crest regulators
such as irx1/2/3, cyp26c1, nrp1, pdgfra, olig4, (Alarcon et al., 2008;
Bellefroid et al., 1998; Hernandez-Lagunas et al. 2011; Itoh et al.,
2002; Liu et al., 2002; Martinez-Morales et al. 2011; Reijntjes et al.,
2004; Rodriguez-Seguel et al., 2009; Schwarz et al., 2009; Tallquist
and Soriano, 2003). In addition, several transcripts such as plekhn1,
prtg, tfap2e, dact1, axin2, and ror2 remain to be analyzed in neural
border/crest development. Interestingly, dact1, axin2, ror2 partici-
pate in Wnt signaling which promotes neural crest development.
The neural crest is efﬁciently induced with the combination of
Pax3 and Zic1 expression at appropriate relative levels (Hong and
Saint-Jeannet, 2007; Milet et al., 2013). We tested the effect of Zic1
expression in Pax3GR-induced animal caps in the presence of
cycloheximide. Among the 55 transcripts enriched more than 2-
fold and less than 4-fold compared to Pax3 alone, two belonged to
the NC gene signature (dusp5, c3) and among the 21 transcripts
enriched more than 4-fold compared to Pax3 alone, three
belonged to the NC signature (glipr2, axin2, snail1). This suggested
that novel genes are activated when Zic1 is expressed (glipr2, c3,
dusp5) and that Pax3 and Zic1 can synergize to drive axin2 and
snail1 expression (Fig. 3B).
We further validated these results by RT-qPCR, in order to
conﬁrm Pax3 targets, Zic1 targets and Pax3/Zic1 targets (Fig. 3C
and data not shown). These were done in several independent
experiments in the same conditions as the ones analyzed on the
microarray, plus the Zic1GR only condition. These analyses vali-
dated three main points (Fig. 3C). Firstly, the main known neural
crest speciﬁers, snail1, snail2 and twist1, were highly and repro-
ducibly activated either by Pax3 (snail2, twist1) or by Zic1 (snail1)
in the presence of cycloheximide. Combining Pax3 and Zic1
seemed to have mild additive effects on snail1 and twist1. Secondly,
the novel putative targets cyp26c1, dusp5, pdgfra, and the known NC
speciﬁer ets1 were activated by either Pax3 alone or Zic1 alone in the
presence of cycloheximide, and their induction seemed potentiated
when both factors are activated (cyp26c1, dusp5, pdgfra), although this
effect was not obtained reproducibly for dusp5 and pdgfra. Thirdly,
axin2was a target of Zic1 alone and its expression was reduced when
Pax3 and Zic1 were combined, yet remained signiﬁcant (in agreement
with its ﬁnding as a target of the Pax3/Zic1 combination compared to
Pax3 alone). Together, these ﬁndings identify several novel
immediate-early targets (thus potential direct targets) for Pax3 and
Zic1 in neural crest induction.
NC signature genes are regulated by Pax3 and/or Zic1 in vivo.
In order to further validate the regulation of these novel direct
targets by Pax3 and Zic1, we conducted knockdown experiments
in vivo, using the previously validated Pax3 and Zic1 antisense
oligonucleotide morpholinos (MO, Monsoro-Burq et al., 2005, de
Croze et al., 2011). Embryos were injected with the MOs into both
blastomeres at 2-cell stage, grown until late neurula stage 17, lysed
and analyzed by RT-qPCR (Fig. 3D). We found that Pax3 depletion
signiﬁcantly reduced the expression of snail2 as expected from
previous studies (Monsoro-Burq et al., 2005), as well as the
expression of snail1, twist1, axin2, c3, cyp26c1, dusp5, ets1, and
pdgfra. This suggested that genes activated by Pax3 in the animal
Table 2
List of genes in the neural crest transcriptome signature.
Molecular function Genes
Transcription factor ets1, foxd3, hoxa2, irf1, irx1/2/3, lmx1b.1, mafb, meis3, msx1/2, olig4, pax3, pou3f1, rara, snai1/2, sox9/10, tcf7, tfap2a/b/e, twist1, zic1
Wnt signaling axin2, dact1, fzd10, ror2, tpbg, wls, wnt1/8a/11b, xarp
Other proteins with
extracellular domain
angpt4, btc, c3, capn8, col18a1, cyyr1, fgfr4, fst, galntl1, hapln3, kal1, kcne5.1, mfap2, mmp14/28, nipal2, nrp1, odz4, pcdh8l, pdgfra, pnhd,
prtg
Other intracellular proteins acta1/c1, bnip3, cyp26c1, dusp5, dynll1, elavl3, fkbp9, glipr2, greb1l, guk1, hsp90aa1.1, irg1, loc100490918, MGC81667, myo10.2, myo1d,
peli1, pfkfb4, plekhn1, pts, rab11ﬁp4l, sdhb, tuba1a, zfp36l2
Gene names follow the Xenbase nomenclature (〈www.xenbase.org〉).
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Fig. 2. Developmental expression of a sample of novel genes belonging to the neural border/crest signature Pax3 and snail2 serve as markers for the lateral neural border and
the premigratory neural crest respectively. Novel markers, identiﬁed in the neural border/neural crest signature, are shown at the most signiﬁcant stages. (A-M,O-T) Dorsal
views, with anterior to the bottom and posterior to the top. (N) Side view.
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cap ectoderm, as immediate-early targets, such as cyp26c1, dusp5,
ets1, pdgfra snail1, snail2, and twist1 (Fig. 3C), were also regulated
by Pax3 in vivo at this late neurula stage. In addition, genes which
were not induced by Pax3 in the presence of cycloheximide in the
blastocoele roof ectoderm, such as axin2 and c3, were also
regulated by Pax3, suggesting indirect regulations in vivo. Simi-
larly, we found that Zic1 morphants displayed a reduced expres-
sion of cyp26c1, dusp5, ets1, pdgfra, snail1, and snail2 (Fig. 3D). All
these genes were signiﬁcantly activated by Zic1 alone in animal
cap ectoderm treated with cycloheximide (Fig. 3C). Twist1 was
Fig. 3. Pax3 and Pax3/Zic1 immediate early target genes in the neural crest signature (A) Experimental strategy used to identify Pax3 and Pax3/Zic1 immediate early target
genes. (B) List of direct targets belonging to the neural crest signature. (C) Independent validation of a subset of targets by quantitative PCR. Embryos were injected as
indicated, either with Pax3GR mRNA, or Zic1GR mRNA, or a combination of both. The animal cap ectodermwas treated with cycloheximide and dexamethasone as described
in the text. (D) In vivo validation of the novel Pax3/Zic1 target genes using by either Pax3 or Zic1 knockdown at stage 17. Abbreviations: Log FC, log 2 fold change.
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neither activated by Zic1 alone, nor downregulated by Zic1 knock-
down in vivo, suggesting that twist is regulated by Pax3 only.
Finally, axin2 was not decreased in Zic1 morphants, although it
was robustly induced in animal cap ectoderm by Zic1 alone.
Further studies will be needed to explore the details of this
complex regulation.
Fig. 4. Identiﬁcation of Pax3 and Zic1 binding sites on Snail1/2 promoters in vitro (A) Induction of snail2 between stage 11.5 and 14 is strongly reduced by Pax3 knock-down, but
only mildly affected by Zic1 knock-down. (B) The increase in snail1 transcription between stage 11.5 and 14 is blocked by both Pax3 and Zic1 knock-down. (C) Location of the ECRs
studied here (yellow boxes), containing Pax3 or Zic1 putative binding site (B.S.), in the genomic sequence upstream of snail1 and snail2 transcription start site (TSS). (D) Pax3 binds
speciﬁcally to the motif identiﬁed in the snail2 promoter ECR: the electrophoretic mobility of a radiolabeled oligonucleotide containing the putative Pax3 B.S. (Pax3BS) is shifted in
the presence of Pax3-transfected cell extract, but not with the non-speciﬁc (N.S) control (i.e. GFP-transfected cell extract). Intensity of the shift is reducedwhen the Pax3 binding site
is mutated (mut. Pax3BS). In the presence of a speciﬁc anti-Pax3 antibody, we detect a mobility supershift, indicating that the Pax3 protein is indeed responsible for the observed
shift. (E) Zic1 binds speciﬁcally to the motif identiﬁed in the snail1 ECR: the electrophoretic mobility shift detected in the presence of Zic1-transfected cell extract can be competed
by increasing doses of non-labeled oligonucleotide (Zic1BS), but only weakly by the mutated oligonucleotide (mut. Zic1BS).
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Snail genes induction requires Pax3 and Zic1 in vivo, and their
promoter contains putative Pax3 and Zic1 binding sites.
Because snail1 and snail2 are two key neural crest speciﬁers, we
have investigated in more details whether Pax3 and Zic1 were
required in vivo for their early induction at the neural border and
could also bind regulatory elements in their promoter. Snail1 is
expressed in the mesoderm during gastrulation and starts to be
expressed at the neural border along with snail2 at stage 11.5
(Essex et al., 1993). Accordingly, snail1 and snail2 transcripts
increased in whole wildtype embryos, from stage 11 to stage 14,
when measured by RT-qPCR (Fig. 4A and B). When knocking down
Pax3, we observed that both snail1 and snail2 levels remained
comparable to stage 11.5 levels, indicating that Pax3 is required for
the induction of both genes at the neural border. In contrast, knocking
down Zic1 prevented any signiﬁcant increase in snail1 expression, but
only marginally affected snail2 early activation (Fig. 4A and B).
Together with the potent induction of snail1 by Zic1 and of snail2
by Pax3 in cycloheximide-treated animal cap ectoderm (Fig. 3C),
these results indicate that Zic1 is essential for snail1 induction at the
neural border, while Pax3 is key to activate both genes in vivo during
gastrulation and early neurulation, but activates efﬁciently only snail2,
as an immediate-early target in ectoderm explants.
We next looked for putative binding sequences (BS) for
these two transcription factors in the evolutionary conserved
non coding regulatory elements (ECR, using rVista) located up to
3 kb upstream of each coding sequence using the X. tropicalis
genome. Transfac and Jaspar transcription factor binding motifs
databases were used to predict potential binding sites. A putative
Pax3 site (Pax3BS) was found in the snail2 promoter, and a Zic1
putative site (Zic1BS) was found in a conserved element located
1.5 kb upstream of snail1 translation start site (TSS, Fig. 4C).
Double-stranded oligonucleotides were end-labeled for EMSA
analysis. Optimal Zic1 and Pax3 binding sequences served as
positive controls, while mutated Zic1 and Pax3 binding sequences
served as negative controls (Vogan et al., 1996; Table S1). Snail1 and
snail2 oligonucleotides were designed according to the genomic
sequences identiﬁed above, and snail1 and snail2 oligonucleotides
were mutated on the putative binding sites served as negative
controls. We showed that Pax3 binds efﬁciently to snail2 oligonucleo-
tide but much less to the oligonucleotide mutated in the putative
binding site (Fig. 4D). Moreover, an antibody against Pax3 induced a
supershift of the snail2 oligonucleotide, which did not occur in the
presence of a non-speciﬁc antibody (Fig. 4D). Similarly, we showed
that Zic1 binds to snail1 putative oligonucleotide but not to the snail1
oligonucleotide mutated on the putative binding site (Fig. 4E and not
shown). Moreover, Zic1 binding on snail1 oligonucleotide was efﬁ-
ciently competed by increasing amounts of cold snail1 oligonucleotide
but not by increasing amounts of the mutated snail1 oligonucleotide,
conﬁrming the speciﬁcity of Zic1 binding (Fig. 4E). Together, these
data indicate that the snail1 and snail2 promoters contain putative
binding sites for Zic1 and Pax3 respectively, which may mediate the
direct activation of these immediate-early targets of Zic1 and Pax3.
Pax3 controls its own transcription.
Finally, one intriguing result from the microarray analysis was
the potential autoregulation of pax3 gene transcription by Pax3
itself (Fig. 3B). We designed pax3 PCR primers located in the UTRs
in order to detect endogenous pax3 transcription but not the
injected pax3 mRNA (devoid of UTRs) (Table S1). Using these
endogenous-pax3-speciﬁc primers, we showed that endogenous
pax3 transcription was activated in animal cap ectoderm injected
with either Pax3 alone or Pax3þZic1 combination and treated
with cycloheximide (31 and 16-fold increase respectively com-
pared to the cycloheximide-treated uninjected caps, Fig. 5A),
Fig. 5. Identiﬁcation of Pax3 binding sites on Pax3 promoters in vitro (A) Pax3, but not
Zic1 alone, can trigger synthesis of the endogenous Pax3 transcript (primers in 30UTR,
not amplifying the inducible form) either in absence of the translation inhibitor
cycloheximide (induction is 5-fold compared to uninjected animal caps) or in the
presence of cycloheximide (induction is 31-fold, compared to cycloheximide-treated
uninjected animal caps). Endogenous pax3 expression level in a stage 11 whole embryo
is set at a relative value of 1 unit. After co-injection of Pax3 and Zic1, endogenous pax3
was activated as an immediate-early target as well (77-fold compared to uninjected
animal caps; and, in presence of cycloheximide, 16-fold when compared to cyclohex-
imide-treated uninjected animal caps). (B) Location of the ECR containing Pax3 putative
binding site in the genomic sequence upstream of the Pax3 TSS. (C) Pax3 binds
speciﬁcally to the motif identiﬁed in the pax3 promoter ECR: an electrophoretic mobility
shift of the radiolabeled Pax3 binding site (Pax3BS) oligonucleotide probe is detected in
the presence of Pax3-transfected cell extract, but not with the GFP-transfected cell
extract. Intensity of the shift is reduced when the Pax3 binding site is mutated (mut.
Pax3BS). In the presence of a speciﬁc anti-Pax3 antibody, we detect a supershift,
indicating that the Pax3 protein is indeed responsible for the observed shift.
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whereas Zic1 alone did not signiﬁcantly induce pax3. Similar
conclusions were also obtained using the other translation inhi-
bitor emetine (not shown). While the addition of cycloheximide
was needed to ensure that this induction did not require de novo
protein translation, it also slightly modiﬁed endogenous pax3
expression in the absence of mRNA injection. Moreover, it is well
documented that cycloheximide produces a superinduction effect
(Tadano et al., 1993). Thus, as a control, we also tested pax3
induction in the absence of cycloheximide: either Pax3 alone or
Pax3þZic1 combination induced endogenous pax3 expression (5
and 77-fold respectively compared to control uninjected caps),
whereas Zic1 had no effect. These results indicate that pax3 gene is
an immediate-early target of its own protein product Pax3.
Using an in silico approach similar to the one described above, we
looked for Pax3 binding sites in pax3 gene regulatory sequences. We
found several putative binding sites in ECRs, either 0.5 kb or 1.5 kb
upstream of pax3 TSS (Fig. 5B). Using EMSA, we show that Pax3 can
bind to the conserved element located 1.5 kb upstream of pax3 TSS,
but not to the equivalent oligonucleotide mutated on the putative
Pax3 binding site (Fig. 5C). In addition, the oligonucleotide was
supershifted by the Pax3 antibody but not by a control antibody
(Fig. 5C). These data show that Pax3 exerts a positive autoregulation
on its own transcription and suggest new putative regulatory elements
mediating this regulation. This kind of regulation involving a positive
feedback loop is novel in the neural crest gene regulatory network and
may be used to stabilize the key neural border gene expression and
lock cells in a neural border fate during early neurulation.
Discussion
The initial regulatory steps of the neural crest gene network
remain poorly understood. In particular, the links between neural
border establishment and premigratory neural crest induction
involve key transcription factors such as Pax3 and Zic1, but the
genes directly targeted by those factors remained unknown. In this
study, we have ﬁrst deﬁned a novel gene signature for the neural
border and the premigratory cephalic neural crest in X. laevis
embryos. Using a microarray-based approach, we then have
devised methods to identify early regulators of neural crest
induction. We have speciﬁcally focused on the establishment of
the premigratory neural crest within the neural border and on the
targets of Pax3 and Zic1 since these two factors cooperate and are
sufﬁcient to trigger neural crest development (Milet et al., 2013).
We have selected 81 genes robustly expressed at the neural border
in mid-neurulae and in the premigratory neural crest, but not in the
brain-forming anterior neural fold (Fig. 1, Tables 1 and 2, S2). Using
this novel early NC signature, we have then looked for immediate-
early targets of Pax3 and Zic1 using three assays: neural crest
induction in the pluripotent ectoderm of the animal cap (Fig. 3A–C;
Milet et al., 2013), in vivo validation using Pax3 and Zic1 morpholinos
(Fig. 3D), and validation of putative binding sites in vitro (Figs. 4 and
5). These results allowed us to propose an extended gene regulatory
network centered on Pax3, and comprising 21 novel Pax3 putative
direct targets. In addition, we have validated three novel Zic1 targets
(Figs. 3 and 6). Finally, we have demonstrated Pax3 positive auto-
regulation (Fig. 5), introducing a novel feedback loop in the neural
border network, and we have evidenced a direct link between the
neural border speciﬁers Pax3 and Zic1 and the activation of several
key actors of the epithelium to mesenchyme transition (EMT) in the
neural crest, namely snail1, snail2, foxd3, and twist1.
Deﬁning a premigratory neural crest gene signature.
Two large scale transcriptomic approaches have previously
been used to study neural crest development: both focused on
the early migrating neural crest cells, either in chick or human
embryos (Gammill and Bronner-Fraser, 2002; Thomas et al., 2008).
While these studies highlighted the expression of many genes
involved in cell shape, cell migration and adhesion, our study
provides a novel group of known and putative regulators acting
upstream of EMT, emphasizing that early induction involves a
major proportion of transcription factors and cell signaling mole-
cules. Indeed transcription factors and the Wnt signaling pathway
were both signiﬁcantly enriched (po0.01) in the neural crest
signature. Using two complementary approaches, i.e. dissection of
control embryo tissues and gain-of-function in animal cap plur-
ipotent ectoderm, we have selectively identiﬁed genes relevant for
neural crest development, although, despite well controlled dis-
sections, two transcripts out of 83 were encoding cardiac actin
which is abundantly expressed in contaminating mesoderm (actc1,
acta1; Hemmati-Brivanlou et al., 1990; Della Gaspera et al. 2012).
Likewise, because superﬁcial ectoderm was included with the
neural crest explants, three superﬁcial ectoderm markers were
also found (fkbp9, irg1, guk1; Chalmers et al., 2006). However, the
cluster that we chose as the “premigratory neural crest signature”
contains the main known neural crest speciﬁers (ets1, foxd3, snai1/
2, sox9/10, twist1), the neural border speciﬁers (msx1/2, pax3,
tfap2a/b, zic1) and genes involved in dorsal neural tube and neural
crest patterning (hoxa2; irx1/2/3, mafb, meis3, olig4). This result
validates our bioinformatics screening strategy and suggests
similar roles for the novel transcription factors identiﬁed (irf1,
lmx1b.1, pou3f1, rara, tcf7, tfap2e). Moreover, our premigratory
neural crest signature contains numerous factors with other
functions than DNA binding, which also could display essential
roles upstream of EMT. We have validated the expression of eight
such novel genes at the neural border, some being expressed in the
migrating neural crest as well (Fig. 2).
By design, our study was limited to the 15,000 probesets (about
10,000 genes) present on the Affymetrix arrays. This represents
about one third of the frog genes. In order to deﬁne the full
complement of genes activated at the neural border in the
premigratory neural crest, further analysis using next generation
sequencing will be used. Moreover, we have focused on the genes
expressed robustly by deﬁning a minimal expression threshold
prior to the unsupervised clustering analysis, and presenting a low
p-value (o2.5%) for the differential expression. Doing so, we may
have overlooked important but weakly or broadly expressed
regulators. Finally, our design has focused on genes enriched in
the lateral neural border compared to the anterior neural fold, thus
excluding potential regulators evenly expressed all around the
neural border. Such genes, e.g. zic2, may nonetheless cooperate
with neural crest-speciﬁc genes to activate EMT. In conclusion, we
have limited the proposed signature to a group of 83 genes, which
are likely to be most speciﬁc for neural border and premigratory
neural crest. Our 83-gene signature shares several neural crest
speciﬁers with previous analyses in chick and human migrating
neural crest (Gammill and Bronner-Fraser, 2002; Thomas et al.,
2008). This signature will be useful to deﬁne the premigratory
neural crest step in differentiation protocols from stem cells
(Bajpai et al., 2010; Mica et al. 2013).
Deﬁning an improved neural crest gene regulatory network centered
on Pax3 targets.
An initial gene regulatory network controlling neural crest
development, composed of many epistatic relationships between
neural border/crest regulators, was proposed based on expression
patterns and functional studies in vivo (Meulemans and Bronner-
Fraser, 2004). A few direct interactions have been documented (e.g.
on sox10, pax3, ecad regulation, Betancur et al., 2010; de Croze
et al., 2011; Cano et al., 2000). However, the direct targets of most
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transcription factors and signaling pathways remain to be identi-
ﬁed (reviewed in Rogers et al., 2012). In our study, we focus on the
putative direct targets of Pax3, because it is essential and, when
combined to Zic1, sufﬁcient to activate neural crest EMT, migra-
tion, and differentiation (Milet et al., 2013).
More speciﬁcally, we have focused on Pax3 immediate-early
target genes belonging to the neural crest signature deﬁned above
(Fig. 3). For example, muscle-speciﬁc Pax3 targets activated in the
animal cap ectoderm were discarded (e.g. myf5). We found that
several key neural crest speciﬁers were activated under these
conditions: foxd3, snail1, snail2, and twist1. When Zic1 was added,
snail1 and axin2 were better activated (Fig. 3C). We conﬁrmed that
snail1 is an immediate-early target of Zic1 as shown in animal caps
neuralized by Noggin (Cornish et al., 2009). In contrast, we found
only two genes that belong to the neural crest signature which
were downregulated when Pax3 was activated (glipr2, tub1a;
p45%). This suggests that Pax3 plays mostly an activating role
on neural crest signature genes.
In addition, we found binding sequences for Pax3 and Zic1
upstream of snail1 and snail2 coding sequences, which were
validated for binding in vitro, suggesting that Pax3 and Zic1 may
regulate snail genes directly in vivo (Fig. 4). Snail genes cooperate
with foxd3 and soxE factors to activate EMT, survival and prolifera-
tion of neural crest cells (Cheung et al., 2005). One important
question prior to this study was whether neural border speciﬁers
Pax3 and Zic1 would directly activate several neural crest speci-
ﬁers, or if they would trigger a cascade of gene activations, one
being dependent upon the previous one. Our ﬁndings suggest the
direct and parallel activation of several neural crest speciﬁers by
the combined action of Pax3 and Zic1, thus explaining how these
two factors are sufﬁcient to trigger efﬁcient neural crest
development (Milet et al., 2013). In addition to the known neural
crest speciﬁers, the role of the novel targets identiﬁed here in
neural crest speciﬁcation, EMT and migration awaits future stu-
dies. In particular, several of them may modulate Wnt (axin2,
dact1)
and other signaling pathways (cyp26c1, pdgfra, dusp5) in these
processes.
Additional regulation must occur in vivo for the ﬁne-tuning of
the neural crest induction. Indeed, the timing of activation of these
target genes is not simultaneous, neither in vivo nor in ectodermal
explant assays. (Hong and Saint-Jeannet, 2007; Milet et al., 2013;
Monsoro-Burq et al., 2005). The ﬁne schedule of neural crest
speciﬁers gene activation may be controlled by epigenetic regula-
tions (Strobl-Mazzulla et al., 2010). Moreover these target genes
are not activated in the entire neural border territory. Finally, some
genes are found only weakly induced in our assays whereas they
are robustly expressed in vivo, suggesting that additional regula-
tors potentiate Pax3 and Zic1 action in the embryo.
Among Pax3 targets, pax3 itself was found, as shown with
speciﬁc assays for injected versus endogenous pax3 transcripts,
consistent with our ﬁndings of Pax3 binding sites in evolutionary
conserved elements upstream of its own promoter (Fig. 5). This
ﬁnding indicates a novel positive feedback loop within the neural
crest GRN, which suggests a mechanism for neural border main-
tenance as hypothesized in de Croze et al., 2011. Finally, we found
that several novel targets, i.e. c3, cyp26c1, dusp5, pdgfra, and twist1,
were better activated by the combined action of Pax3 and Zic1
rather than either one alone. This is the ﬁrst indication of an
additive effect of these two factors, on the expression of genes
belonging to the premigratory neural crest signature.
Altogether, our results allow us to provide a much improved
network described in Fig. 6: at the neural border, Pax3 cooperates
with Zic1, both factors being part of a “bottleneck” in the neural
crest GRN since activating those two genes is both necessary and
sufﬁcient for neural crest development (Milet et al., 2013). Each
factor activates several downstream neural crest speciﬁers or
putative neural crest regulators, and both factors synergize to
activate some common targets. These observations enrich our
understanding of the larger neural crest gene regulatory network.
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Fig. 6. Model of the Pax3/Zic1-linked neural crest gene regulatory network This
model summarizes the targets of Pax3 and of Pax3 combined to Zic1, validated in
this study. Red arrows indicate Pax3 targets, blue arrows indicate Zic1 targets. Bold
arrows indicate that regulation by Pax3 or by Zic1 was conﬁrmed by RTqPCR and/or
in vivo.
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